QuidelOrtho reported third-quarter 2026 revenue of $619 million, down 12% from the prior year, and a GAAP net loss of $54 million, or $0.78 per diluted share. The company lowered its top-end 2026 guidance for adjusted diluted EPS to $0.65 to $0.70 from $0.65 to $0.90, and launched a restructuring program it expects to save over $80 million a year in 2027, with $30 million to $35 million in one-time charges in the fourth quarter of 2026.
Q3 2026 revenue $619 million, down 12%; Point of Care revenue fell 27% on a softer respiratory season
Q3 GAAP net loss $54 million ($0.78 per share); adjusted diluted EPS $0.31
2026 guidance: revenue $2.52 to $2.54 billion; adjusted EBITDA $540 to $545 million; adjusted EPS $0.65 to $0.70 (previously $0.65 to $0.90)
Effective November 9, 2026, Chief Operations Officer Phil McLellan's role is eliminated; Jonathan Siegrist and Bryan Hanson named heads of the two new businesses
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From QuidelOrtho's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$2.73B
-1.9%
$-16.69
—
-41.5%
FY2024
$2.78B
-7.2%
$-30.54
—
-73.7%
FY2023
$3.00B
-8.2%
$-0.15
-101.6%
-0.3%
FY2023
$3.27B
+92.3%
$9.56
-41.8%
16.8%
FY2022
$1.70B
+2.2%
$16.43
-11.7%
41.5%
Frequently asked questions
When is QuidelOrtho's next earnings date?
QuidelOrtho has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did QuidelOrtho earn last quarter?
For the quarter ended Sep 2026, QuidelOrtho reported diluted EPS of $-0.78 on revenue of $618.90M (-11.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.